Patented Medicine Prices Review Board

The Patented Medicine Prices Review Board (PMPRB) protects and informs Canadian consumers by ensuring that the prices of patented medicines sold in Canada are not excessive, and by reporting on pharmaceutical trends.

We are an independent quasi-judicial body that is part of the Health portfolio, and operate at arm’s-length from the Minister of Health.

We are in the process of moving our services and information to Canada.ca.

Our current Patented Medicine Prices Review Board website will remain available until the move to Canada.ca is complete.

Follow:

Twitter

Latest

Promotions

After several years of low growth, public drug plan expenditures up sharply in 2015-16
2017-05-24 – News release
A new Patented Medicine Prices Review Board report reveals that prescription drug expenditures by Canadian public drug plans reached $11.3 billion in 2015-16, up $1 billion over the previous year.

Statement by Patented Medicine Prices Review Board Vice-chairperson on consultation on potential changes to the Patented Medicines Regulations
2017-05-16 – Statement
Patented Medicine Prices Review Board Vice-chairperson Dr. Mitchell Levine made a statement on the launch of Health Canada’s consultation on potential changes to the Patented Medicines Regulations.

Patented Medicine Prices Review Board will hear closing arguments in the matter of the price of Soliris
2017-04-12 – News release
Closing arguments in the matter of the price of the patented medicine Soliris will be heard from Patented Medicine Prices Review Board staff, Alexion Pharmaceuticals Inc., and the intervenor, BIOTECanada, on Tuesday, April 18 and Wednesday, April 19, 2017, from 9:00 a.m. to 4:30 p.m. (EST)

Meds Entry Watch 2015 — High-price specialty drugs dominate international new drug launches and sales in 2015
2017-04-11 – News release
The Patented Medicine Prices Review Board, through the National Prescription Drug Utilization Information System research initiative, today published the first edition of Meds Entry Watch, a new annual publication that provides information on recently launched drugs in Canada and select international markets.

Patented Medicine Prices Review Board News Releases

All news

Our services and information

New patented medicines reported to the PMPRB

Search for new patented medicines reported to the PMPRB by keyword, status, and/or year reported.

Regulatory process

Find information on the PMPRB’s regulatory and investigative process.

Are you a patentee?

Find information on the PMPRB’s statutory reporting requirements, guidance on filing requirements and deadlines for patentees, outreach presentations and recorded Webinar sessions, and answers to frequently-asked questions.

Reports and trends

Find information on key trends in sales and prices of patented drug products, and in drug manufacturers’ investments in pharmaceutical research and development.

The Hearing process

Find information on the PMPRB’s hearing process, the status of ongoing proceedings, and a listing of Board decisions and orders.

What we are doing

Laws and regulations

All related laws and regulations

Publications

Consultations

All related consultations

Policies

Features

Regulating prices

The Patented Medicine Prices Review Board is responsible for ensuring the prices that patentees charge for prescription and non-prescription patented medicines sold in Canada to wholesalers, hospitals, pharmacies or others, for human and veterinary use, are not excessive.

Pharmaceutical trends

The Patented Medicine Prices Review Board reports annually to Parliament through the Minister of Health on its price review activities, the prices of patented medicines and price trends of all prescription drugs, and on the research-and-development expenditures reported by pharmaceutical patentees.

National Prescription Drug Utilization Information System (NPDUIS)

The National Prescription Drug Utilization Information System (NPDUIS) is a research initiative jointly conducted by the Patented Medicine Prices Review Board and the Canadian Institute for Health Information. NPDUIS provides policy-makers and drug plan managers with information and insight on trends in pharmaceutical prices, use, and costs.

Language selection

Search